Cellebrite
CLBT
46 hedge funds and large institutions have $196M invested in Cellebrite in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 9 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
0.32% less ownership
Funds ownership: 20.63% → 20.31% (-0.32%)
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
6% less funds holding
Funds holding: 49 → 46 (-3)
21% less capital invested
Capital invested by funds: $247M → $196M (-$51M)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
90% less call options, than puts
Call options by funds: $159K | Put options by funds: $1.52M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$11.8M |
| 2 |
GRIM
Greenhaven Road Investment Management
Greenwich,
Connecticut
|
+$5.57M |
| 3 |
State Street
Boston,
Massachusetts
|
+$423K |
| 4 |
CC
Crosslink Capital
Menlo Park,
California
|
+$357K |
| 5 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$332K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
-$8.96M |
| 2 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
-$7.69M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.13M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$879K |
| 5 |
SAM
Serengeti Asset Management
New York
|
-$256K |
CLBT Hedge Fund Activity: Q2 2022 in Review
46 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q2 2022, worth a combined $196M — down 21% from $247M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CLBT and 6 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 14 added.
The largest buyer was Phoenix Financial, adding an estimated $11.8M. The largest seller was Migdal Insurance & Financial Holdings, exiting entirely with an estimated $8.96M sold.
- 46 institutional investors held Cellebrite (CLBT) as of Q2 2022, down from 49 in Q1 2022.
- Funds reported $196M of Cellebrite stock for Q2 2022, down 21% quarter-over-quarter.
- 6 funds opened new Cellebrite positions in Q2 2022 and 9 closed out, a net change of -3 holders.
- The largest Cellebrite buyer in Q2 2022 was Phoenix Financial, an estimated $11.8M added.
- The largest Cellebrite seller in Q2 2022 was Migdal Insurance & Financial Holdings, an estimated $8.96M sold.
Based on aggregated 13F filings for Q2 2022.